Arlene L. Chow

Arlene L. Chow

Partner, New York

Email arlene.chow@​hoganlovells.com

Phone +1 212 918 3545

Fax +1 212 918 3100

Practice groupIntellectual Property

At the outset, Arlene Chow frames patent litigation matters from the perspective of the judge or jury in order to achieve the best solutions for her clients.

Leveraging her biochemistry experience, Arlene is one of only a handful of lawyers who has been first-chair in district court trials and hearings, federal circuit arguments, and inter partes review hearings before the United States Patent and Trademark Office (USPTO). Arlene is a USPTO-registered patent attorney. She also performs patent due diligence in support of the purchase or sale of drugs or their royalty streams.

Arlene dives deeply into the relevant science and underlying facts before extracting key case themes for development with the case record. She thrives on engaging with in-house and external experts on the science and simplifying the highly technical information in a way that is easy for her clients to digest.

Arlene primarily focuses on life sciences, having worked on matters implicating small molecule and biologic drugs for the treatment of indications, including ulcers; depression; schizophrenia; pneumonia; hemophilia; pain; menopause; anaphylaxis; glaucoma; multiple sclerosis; hypertension; diabetes; COPD; overactive bladder; asthma; overactive thyroid; arthritis; irritable bowel; urinary tract infections; hepatitis; and skin, lung, and prostate cancer. Arlene has also handled matters involving a wide variety of medical devices and dosage forms, including auto-injectors, orally disintegrating and buccal tablets, transdermal patches, spinal devices, sprays, gels, inhalers, gastric bands, and nebulizers.

Awards and recognitions

2018

Intellectual Property: Patent Litigation: Full Coverage
Legal 500 US

2018

Patent Star
Managing Intellectual Property IP Stars

2018

Top 250 Global IP Women
Managing Intellectual Property

Education and admissions

Education

J.D., Columbia Law School, 1998

B.S. Molecular Biophysics and Biochemistry, Yale University, 1994

Memberships

Member, American Intellectual Property Law Association

Member, Intellectual Property Owners Association

Bar admissions and qualifications

New York

California

District of Columbia

U.S. Patent and Trademark Office

Court admissions

U.S. Court of Appeals for the Federal Circuit

U.S. District Court, Northern District of California

U.S. District Court, Southern District of New York

Related Knowledge

3D Printing

Representative experience

As lead counsel for Merck, successfully invalidated Pfizer patent claims relating to polysaccharide-protein conjugate vaccine formulations.

Representing Merck in inter partes review proceedings adverse to GSK relating to polysaccharide-protein conjugate vaccine formulations.

As lead counsel, obtained a permanent injunction for a leading Japanese pharmaceutical firm in a Hatch-Waxman bench trial on infringement and validity.

As lead counsel for patent owner Depomed, obtained favorable written decisions in inter partes review proceedings involving controlled release gastric retentive technology.

Representing BASF as lead counsel in district court litigation and inter partes review proceeding adverse to Nuseed relating to transgenic plants making omega-3 fatty acids.

As lead counsel for patent owner Amgen, obtained favorable written decisions in inter partes review proceedings relating to method of refolding biologic proteins.

Obtained noninfringement, invalidity, and inequitable conduct determinations at bench and jury trials for Photoscribe, a laser manufacturer.

As lead counsel, representing Santen and Asahi Glass in multiple Hatch-Waxman litigations involving glaucoma drug.

Obtained noninfringement determinations at ITC bench trial for Qisda and BenQ, LCD monitor manufacturers.

Obtained summary judgment of invalidity determination for Millennium in relation to urine drug testing protocols.

Loading data